MINERVA SURGICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.001 USD | -99.76% |
|
-99.78% | -99.91% |
| Jan. 03 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
| 2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to the Minerva Surgical...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
Calendar
2024-05-07
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -99.91% | 8.88K | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- UTRS Stock
- News Minerva Surgical, Inc.
- Transcript : Minerva Surgical, Inc., Q2 2023 Earnings Call, Aug 02, 2023
